Showing results (811-820 of 1,190) with videos related to
Sort By:
Pageof 119
BMC Pharmacology & Toxicology|October 12, 2018
Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeksJulián Olalla, Javier Pérez-Stachowski, Begoña Tortajada, et al.BMC Pharmacology & Toxicology|September 26, 2021
Acute and subacute toxicity evaluation of hydroalcoholic extract from the stem bark of Bois Bande (Parinari campestris Aubl.1772) in ratsVenkatesan Sundaram, Stephanie Mohammed, M R Srinivasan, et al.BMC Pharmacology & Toxicology|July 21, 2022
Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viabilityXiao-Mei Yang, Zheng Wu, Xiaoqi Wang, et al.BMC Pharmacology & Toxicology|May 11, 2023
Antitumor effects of erlotinib in combination with berberine in A431 cellsXiangdan Cuan, Xingying Yang, Weiwei Zhu, et al.BMC Pharmacology & Toxicology|August 25, 2020
Prevalence of potential drug-drug interactions and associated factors among outpatients and inpatients in Ethiopian hospitals: a systematic review and meta-analysis of observational studiesWondim Ayenew, Getahun Asmamaw, Arebu IssaBMC Pharmacology & Toxicology|April 14, 2023
Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patientsSarah Farid Fahmy, Marwa Omar El Derany, Hazem Khorshid, et al.BMC Pharmacology & Toxicology|April 25, 2023
Lupeol alleviates atopic dermatitis-like skin inflammation in 2,4-dinitrochlorobenzene/Dermatophagoides farinae extract-induced miceSojung Bae, Na-Hee Jeong, Young-Ae Choi, et al.BMC Pharmacology & Toxicology|August 16, 2020
Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinibA Geneste, M N Duong, L Molina, et al.BMC Pharmacology & Toxicology|August 20, 2020
The anti-apoptotic, antioxidant and anti-inflammatory effects of curcumin on acrylamide-induced neurotoxicity in ratsJie Guo, Xiaolu Cao, Xianmin Hu, et al.BMC Pharmacology & Toxicology|October 12, 2012
No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trialRobert Eggertsen, Ake Andreasson, Lennart AndrénPageof 119